The German company is constructing a new production facility in Lukácsháza. SCHOTT Hungary Kft. is investing more than EUR 100 million to meet the growing demand for so-called high-value solutions.
The company is expanding its capacity for sterile, ready-to-use cartridges at its site in western Hungary and will create over 100 additional jobs in the region. Currently, the company employs 120 people in Hungary.
In 2024, SCHOTT Pharma opened a state-of-the-art production facility for prefillable glass syringes in Lukácsháza. These are used for specialized medications, critical vaccines, and biologics. Since then, two expansion projects have been launched. SCHOTT Group’s total investment in Hungary amounts to nearly HUF 100 billion (around EUR 245 million). Having been present in Hungary for over three decades, the SCHOTT Group is receiving HUF 7.7 billion (EUR 18.8 million) in government support for its current projects, tied to the creation of a total of 270 jobs.